IMMXImmix Biopharma, Inc.
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -89% · now 36% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can IMMX take a bad year?
The deepest fall in IMMX's price history on file is −89%; it is 36% below its high today.
Worst drawdown on file · −36% today
- Cash runway
- 5+ years
Cash runway · burning $9.8M a quarter at the current rate
- Annualised volatility
- 88%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $232M
- EBITDA, trailing twelve months
- −$41M
- Operating profit, trailing twelve months
- −$42M
- Annualised volatilitytwo years of daily moves
- 88%
- Worst drawdown on file
- −89%
- Below its 52-week high
- 36%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.